Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China by unknown
EUROPEAN JOURNAL 
OF MEDICAL RESEARCH
Wang et al. European Journal of Medical Research 2013, 18:11
http://www.eurjmedres.com/content/18/1/11RESEARCH Open AccessClinical significance of combined detection of
human papilloma virus infection and human
telomerase RNA component gene amplification in
patients with squamous cell carcinoma of the
esophagus in northern China
Yu-Feng Wang, Xin-Shuai Wang, She-Gan Gao, Qiang Chen, Yan-Tong Yang, Zhong-Yue Xiao, Xiu-Qing Peng,
Xiu-Feng Hu, Qia-Yin Wang and Xiao-Shan Feng*Abstract
Background: The aim of the study was to test for human papilloma virus (HPV) infection and human telomerase
RNA component (hTERC) gene amplification in tissues derived from esophageal cancer, in esophagus displaying
atypical hyperplasia and in normal tissue, and to analyze the relationship between them and discuss whether HPV
infection and hTERC gene amplification play a role in the duration of survival of esophageal cancer patients.
Methods: To test for HPV infection, surface plasma resonance was used after extracting and subjecting the DNA to
PCR amplification. Measurement of hTERC gene amplification was performed by the fluorescence in situ
hybridization technique.
Results: The rates of HPV infection in the normal group, the atypical esophageal hyperplasia group and the cancer
group were 0% (0/40), 10.00% (1/10) and 20.65% (19/92), respectively, with a statistically significant difference of
P < 0.01. The hTERC gene amplification rate in normal tissue, grade I atypical hyperplastic tissue, grade II/III atypical
hyperplastic tissue and esophageal cancer tissue were 0% (0/89), 15.38% (4/26), 47.06% (8/17) and 89.13% (82/92),
respectively, with a statistically significant difference of P < 0.01. On follow-up of 92 patients, survival curves of the
HPV-positive and HPV-negative groups were not significantly different (P > 0.05). Survival curves of the hTERC gene
amplification-positive and hTERC gene amplification-negative groups were statistically significant (P < 0.05). A
matching chi-square test showed that there was no correlation between HPV infection and hTERC gene
amplification (P > 0.05).
Conclusion: HPV infection may be one of many factors contributing to the development of esophageal cancer, but
it does not influence prognosis. Amplification of the hTERC gene appears to influence certain features associated
with postoperative survival in esophageal carcinoma patients.
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China has the highest incidence and mortality of squa-
mous cell carcinoma of the esophagus (ESCC) in the
world. Patients with ESCC are most commonly diag-
nosed with locally advanced tumor stages. Early meta-
static disease and late diagnosis are common reasons
responsible for the poor clinical outcome of this tumor.
The prognosis of ESCC is very poor because of the pau-
city of symptoms seen in these patients at the earliest
stages of disease. Progressively increasing epidemiologic
and biologic evidence indicates that human papilloma
virus (HPV) infection is associated with the occurrence
of ESCC [1-3]. In cervical cancer, the human telomerase
RNA component (hTERC) gene may influence the inte-
gration of HPV into the cellular genome, accumulation
of numerical chromosome aberrations and development
of genomic instability with a consistent gain of chromo-
some arm 3q. Hopman and colleagues showed that both
the genomic integration of oncogenic HPV and gain of
the hTERC gene appeared to be important genetic
events that were associated with the progression of uter-
ine cervical dysplasia to an invasive cancer [4]. In ESCC,
there is also a gain of chromosome arm 3q [5]. By taking
into account that ESCC and cervical cancer are both
squamous cell carcinomas, we explored whether HPV
infection and the hTERC gene in ESCC display similar
mechanisms in the pathogenesis of cervical cancer.
Methods
Materials
Ninety-two specimens of freshly frozen ESCC were col-
lected from December 2007 through December 2008 at
the First Affiliated Hospital of Henan University of Sci-
ence and Technology. Esophageal cancer tissue, esopha-
geal cancer side tissue (approximately 2 cm) and normal
tissue were selected and made into sectioned wax pieces.
Ninety-two cases of esophageal cancer tissue, 26 cases of
grade I esophageal atypical hyperplastic tissue, 17 cases
of grade II/III esophageal atypical hyperplastic tissue and
89 cases of esophageal normal tissue were selected, and
their pathology was confirmed. Ten cases of esophageal
atypical hyperplastic tissue and 40 cases of normal tissue
were collected by endoscopic examination over the same
period. This study was conducted in accordance with
local ethics guidelines compliance with the Helsinki
Declaration, the patients’ esophagus tissues used in this
study were approved by the Medical Ethics Committee
of the First Affiliated Hospital of Henan University of
Science and Technology, Luoyang, China, reference no.
2010006.
Methods and apparatus
DNA was isolated from frozen esophageal mucosa using
the TIANamp Genomic DNA Kit (Tiangen Biotech(Beijing) Co., Ltd, Beijing, China). Excised tissue (20 μg)
in liquid nitrogen was ground until the tissue was pow-
der. Liquid nitrogen was allowed to evaporate and the
powdered tissue added to buffer GA (200 μl), and then
RNAase was added to a final concentration of 2 μg/μl,
mixed and incubated for 30 minutes at 37°C. Proteinase
K was added to a final concentration of 100 μg/μl and
placed in a water bath for 3 hours at 56°C. Buffer GB
(200 μl) was added, mixed and incubated for 10 minutes
at 70°C. Ethanol was then added, and the solution mixed
and transferred to a spin column that was closed and
placed in the microcentrifuge. The mixture was
centrifuged for 1 minute at 13,400 × g, the filtrate
discarded and the spin column placed in the
microcentrifuge. Buffer GD (500 μl) was added and
again the mixture was centrifuged for 1 minute at
13,400 × g, the filtrate discarded and the spin column
placed in the microcentrifuge. Buffer PW (600 μl) was
added, and the mixture was centrifuged for 1 minute at
13,400 × g, the filtrate discarded and the spin column
placed in the microcentrifuge. TE (50 μl) was then
centrifuged for 2 minutes at 13,400 × g, and the filtrate
collected. The DNA concentration was measured using
a Nanodrop 1000 (Thermo Scientific, Waltham, MA,
USA), an A260:A280 ratio of 1.75 to 2.05 indicating an ab-
sence of contaminating proteins. The isolated DNA was
amplified by the HPV L1 consensus primers MY11 and
MY09 [6].
The PCR processes were monitored through amplifica-
tion of part of the human β-actin gene in replicate tubes
with related primers [7]. Each PCR (50 μl) mixture
consisted of 5 μl of 10× buffer (Mg2+), 2.5 mM MgCl2,
200 μM each dNTP, 0.2 μM my11/my09, 2.5 U Taq and
2 μl template DNA. Amplification without DNA tem-
plate was used to monitor contamination in both the
HPV and β-actin reactions. An HPV-positive sample was
considered the positive control (Beijing GP Medical
Technology Co., Ltd, Beijing China). The mixtures were
incubated for 3 minutes at 94°C; then for 20 seconds at
94°C, 30 seconds at 55°C, 30 seconds at 72°C for 40 cy-
cles; for 5 minutes at 72°C; and at 4°C on hold. A 10 μl
aliquot of the PCR mixture was visualized by ethidium
bromide staining after agarose gel electrophoresis. HPV-
positive samples reveal a band of approximately 450 base
pairs.
Surface plasma resonance (SPR) technology is a novel
method to detect the HPV genotype. SPR exploits sur-
face plasmons (special electromagnetic waves) that can
be excited at certain metal interfaces, most notably silver
and gold. When incident light is coupled with the metal
interface at angles greater than the critical angle, the
reflected light exhibits a sharp attenuation (SPR mini-
mum) in reflectivity owing to the resonant transfer of
energy from the incident light to the surface plasmon.
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ance occurs is highly dependent on the refractive index
in the immediate vicinity of the metal surface. Binding
of molecules at the surface changes the local refractive
index, resulting in a shift of the SPR minimum angle. By
monitoring changes in the SPR signal, it is possible to
measure binding activities at the surface in real time.
The SPR instrument and the PCR and SPR kits were
obtained from Beijing GP Medical Technology Co., Ltd.
The peltier-based thermal cycler was obtained from the
Hangzhou LongGene Scientific Instruments Co., Ltd
(Hangzhou, Zhejiang, China). A probe panel based on
the hTERC gene sequence was designed to evaluate the
gain of chromosome 3q. The probes and the fluores-
cence in situ hybridization kit were obtained from
Beijing GP Medical Technology Co., Ltd. Microscopic
images were acquired using an Olympus B Microscope
equipped with custom optical filters for 4,6-diamidino-2-
phenylindole, spectrum green and spectrum red, as well
as a Plan Apo objective. The fluorescence in situ hybridi-
zation IMSTAR 3.0 image analysis system was used
(CYTOGEN, IMSTAR, Paris, France). All procedures
were conducted in accordance with the product instruc-
tion manual.
Evaluation criteria
The SPR gold chip was immobilized with 24 types of
specific HPV probes targeting the L1 region of HPV
genome. In addition, one positive control probe (spe-
cific to the human β-actin gene) and one negative con-
trol probe (unrelated to both HPV and human genome
sequences) were also spotted on the gold chip. For an
informative reaction, the positive control probe spot
should yield a positive hybridization resonance unit,
the negative control probe spot a negative hybridization
resonance unit and the rest of the HPV probe spot dif-
ferent hybridization resonance units, depending on the
HPV status existing in each specimen. A positive con-
trol signal value <40 or a negative control signal value
≥40 were indicative of obtaining an invalid result. A
positive control signal value ≥40 and negative control
signal value <40 were indicative of obtaining a valid re-
sult. For the 24 types of specific HPV probes, a probe
signal ≥40 was considered HPV-positive and a signal
<40 was considered HPV-negative. The cutoff value
was set at 17.3 per 100 random nuclei displaying in-
creased hTERC signals and/or tumor ploidy (for more
detail see Results).
Statistical analysis
For the evaluation of the data, SPSS 17.0 statistical soft-
ware (SPSS Company, Chicago, IL, USA) was used to
perform the chi-square test. The follow-up data obtained
from different subgroups of patients with esophagealcancer were assessed by Kaplan–Meier survival analysis
and use of log-rank hypothesis testing of the survival
curves for the different groups. P < 0.05 was considered
statistically significant.
Results
Of 92 cases of cancer tissue, 10 cases of atypical hyper-
plasia tissue and 40 cases of normal esophageal mucosa,
only 20 cases were found to test positive for HPV. The
infection type included the high-risk types HPV18,
HPV35, HPV51, HPV56, HPV66, HPV58, HPV68,
HPV39, HPV81, HPV59 and HPV16, and the low-risk
types HPV42 and HPV54. Mixed infection was found to
exist in five specimens, and four specimens contained
the HPV18 type. The main infection types were found to
be HPV18, HPV35 and HPV51. The HPV infection rates
of normal tissue, atypical hyperplasia of the esophagus
and cancer tissue were found to be 0% (0/40), 10.00%
(1/10) and 20.65% (19/92), respectively, with a statisti-
cally significant difference of P < 0.01. There was no sig-
nificant correlation found between HPV infection and
either gender, age, history of alcohol or tobacco use and
family history (Table 1). Ninety-two patients were
followed for 37 to 49 months after their operation, and
the 3-year survival rate was found to be 51.94%. Survival
curves are shown in Figure 1. The survival analysis
showed that the 3-year survival rate in the HPV-positive
group (19 patients) was 57.02%. The 3-year survival rate
in the HPV-negative group (73 patients) was 50.70%.
Comparison of both survival curves showed that they
were not significantly different (P > 0.05). The survival
curves for the HPV-negative group are shown in
Figure 2.
The signals were visually evaluated by screening the
entire slide for the chromosome 3q-specific probe (using
the spectrum red-specific optical filter). Cells with nor-
mal 3q signal numbers were recorded as diploid. Cells
with abnormal 3q signal numbers were recorded in pat-
terns in the relocation charts of the whole probe panel.
Abnormal nuclei were defined by the recording of more
than two hTERC signals and more than two centromeric
region of chromosome 3 (CSP3) signals. This cutoff
value was based on 35 normal tissues:
Threshold ¼ mean value þ 3 standard deviationð Þ
For normal tissue slides (n = 35), the numbers of
hTERC gene amplification cells (>2 hTERC signals) were
counted in 100 cells of random view, and the mean value
for the 35 normal tissues was 7.1 (standard deviation
3.4). The cutoff value was set at 17.3. A case was consid-
ered hTERC gene amplification-positive for the 3q assay
when >17.3% of the cells exhibited >2 hTERC signals.
Table 1 Relationship between human papilloma virus infection and clinical data
Clinical data Number of cases Positive number Percent positive χ2 P valuea
Gender
Male 56 9 16.07 1.833 0.176
Female 36 10 27.78
Age
>60 years 47 12 25.53 1.396 0.237
≤60 years 45 7 15.56
Smoke
Yes 27 7 25.93 0.649 0.421
No 65 12 18.46
Alcohol use
Yes 32 6 18.75 0.108 0.742
No 60 13 21.67
Family history
Yes 19 5 26.32 0.469 0.494
No 73 14 19.18
aP < 0.05 was considered statistically significant.
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group, the group with grade I dysplasia, the group with
grade II/III dysplasia and the esophageal cancer group
were 0% (0/89), 15.38% (4/26), 47.06% (8/17) and 89.13%
(82/92), respectively, and were statistically significantly
different (P < 0.01). The gene amplification of hTERC in
different differentiation grades, infiltration depth, path-
ology type and lymph node metastasis was found to not
be significantly different (P > 0.05) (Table 2). Survival






















Figure 1 Survival curve of 92 patients.patients) displayed a 3-year survival rate of 47.29%. The
hTERC gene-negative group (10 patients) displayed a 3-
year survival rate of 80%. The survival curves for these
groups were statistically significant (P < 0.05) (Figure 3).
In 92 cases of esophageal carcinoma, 19 cases were
found to be infected with HPV, and in the remaining 73
patients HPV infection could not be detected. In
addition, hTERC gene amplification was detected in 82
cases, and in 10 cases hTERC gene amplification was not






























Figure 2 Survival curves of human papilloma virus-negative and human papilloma virus-positive patients. Human papilloma virus
(HPV)-negative group, n = 73; HPV-positive group, n = 19.
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hTERC gene amplification was detected. In 67 cases, the
existence of hTERC gene amplification in the absence of
HPV infection was found. By contrast, four cases were
negative for hTERC gene amplification in the presence
of HPV infection, and in six cases neither hTERC gene
amplification nor HPV infection was found. The
matching chi-square test showed that there was no cor-
relation between HPV infection and amplification of
hTERC genes (P > 0.05).Table 2 Relationship between clinical pathology and the hum
















aP < 0.05 was considered statistically significant.Discussion
In 1982, Syrjanen and Pyrhonen first reported that HPV
infection was associated with the occurrence of esopha-
geal cancer [8]. Later, many groups studied the relation-
ship between HPV infection and esophageal cancer.
However, the conclusions drawn were inconsistent.
Owing to differences in the detection methods used and
the region of study, the incidence of HPV infection and
the rate of esophageal cancer were reported to range
from 8.70 to 78.11% [3,9]. By contrast, the infection ratean telomerase RNA component genes











































Figure 3 Survival curves of human telomerase RNA component gene-negative and gene-positive patients. Human telomerase RNA
component (hTERC) gene-negative group, n = 10; hTERC gene-positive group, n = 82.
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59.76% [10], even in the same region. Additionally, the
rates of HPV infection were very inconsistent between
different researcher groups [11]. Shen and colleagues
used HPV18E6/E7 to transfect human fetal esophageal
epithelial cells and found that it could induce cellular
immortalization [12]. They concluded that immortalized
cells could arise following malignant transformation
after several generations of cellular proliferation through
mechanisms that depended on the synergistic effect of
the cancer-promoting compounds.
In this study, we used SPR technology to detect HPV
infection in samples from 92 esophageal cancer patients,
10 cases of esophageal atypical hyperplasia and 40 nor-
mal esophageal mucosa cases that were all obtained
from Western Henan province. Infection with HPV in-
cluded the high-risk types HPV18, HPV35, HPV51,
HPV56, HPV66, HPV58, HPV68, HPV39, HPV81,
HPV59 and HPV16, and the low-risk types HPV42
and HPV54. The main infection types were found to be
HPV18, HPV35 and HPV51, and they existed as a mixed
infection. Both HPV16 and HPV18 were closely associ-
ated with the identification of esophageal cancer in
Linzhou city [13]. In this study, the results were not en-
tirely consistent and indicated that different regions dis-
play different types of infection with HPV. There was also
mixed infection found in esophageal cancer patients,
which was similar to observations made in cervical cancer
patients [14].
The infection rate of HPV in the esophagus of normal
subjects, patients presenting with atypical hyperplasiaand patients presenting with esophageal cancer were
found to be 0%, 10.00% and 20.65%, respectively. It is
possible that HPV plays a role in the occurrence of
esophageal cancer. In the normal esophagus group, the
infection rate was found to be 0%, which was concord-
ant with prior observations in the literature for which
the infection rate ranged from 0 to 59.76%. The survival
curves of the positive and negative HPV infection groups
were not significantly different (P > 0.05), suggesting
that HPV infection may not be of prognostic utility in
the evaluation of factors contributing to esophageal
cancer.
The telomere–telomerase hypothesis for activation of
telomerase is closely associated with cell immortalization
and the occurrence or development of malignant tu-
mors. The function of telomeres is to maintain chromo-
some stability and integrity. Telomerase comprises
hTERC, human telomerase reverse transcriptase and hu-
man telomerase binding protein. Telomerase encodes
the telomere repeat sequence that uses its own RNA as
a template (hTERC). Historically, telomerase activity was
thought to be closely associated with human telomerase
reverse transcriptase. In recent years, hTERC has been
of particular importance in regulating telomerase activity
[15]. The hTERC gene, which encodes the telomerase
RNA template, is located on chromosome 3q26.3, and
the region of amplification was found to be 3q26 to
3q27. In our study, the rates of hTERC gene amplifica-
tion in the normal group, the grade I atypical hyperpla-
sia group, the grade II/III atypical hyperplasia group and
the esophageal cancer group were found to be 0%,
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cally significant difference of P < 0.01. These data indi-
cate that the hTERC gene is involved in the
carcinogenesis of esophageal epithelial cells and may
play a role in the occurrence of esophageal cancer. Simi-
lar to observations with cervical atypical hyperplasia,
hTERC gene amplification was closely associated with
different grades of atypical esophageal hyperplasia
[16,17].
The level of gene amplification of hTERC under
conditions of different grades of differentiation, inva-
sion depth, pathology type and lymph node metastasis
was found to be statistically nonsignificant (P > 0.05).
The hTERC gene may participate in the malignant
transformation of esophageal epithelial cells, but it
does not influence tumor invasion and metastasis.
This finding might indicate that amplification of the
hTERC gene is an early event in the development of
esophageal cancer.
The survival curves for the hTERC gene amplification-
positive and hTERC gene amplification-negative groups
were statistically significant (P < 0.05). This observation
suggested that hTERC gene amplification might be an in-
dependent risk factor for the prognosis of esophageal can-
cer. The hTERC gene is anticipated to become a new
target to assist in the treatment of esophageal cancer.
There was no correlation between HPV infection
and hTERC gene amplification in our study. Infection
with HPV and the hTERC gene may have different
pathogenic mechanisms in the development of esophageal
and cervical cancer.
Conclusion
HPV infection may be one of many factors contribut-
ing to the development of esophageal cancer, but it
does not influence prognosis. Amplification of the
hTERC gene appears to influence certain features as-
sociated with postoperative survival in esophageal car-
cinoma patients.
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